dm+d

28395611000001105

New Medicines

Rezolsta (EU), Prezcobix (US)HIV infection in children aged 6-11 years

Information

Rezolsta (EU), Prezcobix (US)
Licence extension / variation
Janssen-Cilag
Janssen

Development and Regulatory status

Phase III Clinical Trials
None
Phase III Clinical Trials

Category

Protease inhibitor & pharmacoenhancing agent - increases systemic levels of coadministered agents that are metabolised by CYP3A
In 2017, 42 children were newly diagnosed with HIV – down from 131 in 2005. All these children were born in other countries [1].
HIV infection in children aged 6-11 years
Oral